Literature DB >> 19407455

Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates.

J Olazarán1, J López-Longo, I Cruz, A Bittini, L Carreño.   

Abstract

Little is known about the mechanisms and relevance of cognitive dysfunction in systemic lupus erythematosus (SLE) patients who never displayed major neuropsychiatric manifestations (nSLE). Thirty-one nSLE female patients and 31 cognitively healthy control women were recruited. Sociodemographic, clinical, neuropsychological and SLE-related markers were collected including cerebral perfusion by single-photon emission computed tomography. Prevalences of cognitive complaints were 22.6% in nSLE versus 6.5% in the control group (p = 0.147); respective prevalences of cognitive dysfunction were 32.3 versus 6.5% (p = 0.01). Within the nSLE group, all cognitive domains appeared similarly affected, and correlations were found between cognitive dysfunction and less skilled occupation (r = -0.41, p = 0.02) and between cognitive complaints and depressive symptoms (r = 0.35, p = 0.05). Cognitive dysfunction is rather frequent in nSLE and seems to negatively impinge on social functioning. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19407455     DOI: 10.1159/000215879

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

1.  Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus.

Authors:  L Plantinga; S S Lim; C B Bowling; C Drenkard
Journal:  Lupus       Date:  2017-02-23       Impact factor: 2.911

Review 2.  Integrative neuroscience approach to neuropsychiatric lupus.

Authors:  Patricio T Huerta; Elizabeth L Gibson; Carson Rey; Tomás S Huerta
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Tumefactive demyelination associated with systemic lupus erythematosus.

Authors:  Rajesh Verma; Kamal Arya
Journal:  BMJ Case Rep       Date:  2012-05-11

Review 4.  Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.

Authors:  Maria B Lauvsnes; Roald Omdal
Journal:  J Neurol       Date:  2011-09-10       Impact factor: 4.849

5.  Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus.

Authors:  Sara G Murray; Jinoos Yazdany; Rachel Kaiser; Lindsey A Criswell; Laura Trupin; Edward H Yelin; Patricia P Katz; Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

6.  Episodic memory impairment in systemic lupus erythematosus: involvement of thalamic structures.

Authors:  Nicolle Zimmermann; Diogo Goulart Corrêa; Tania Maria Netto; Tadeu Kubo; Denis Batista Pereira; Rochele Paz Fonseca; Emerson Leandro Gasparetto
Journal:  Clin Rheumatol       Date:  2015-01-10       Impact factor: 2.980

7.  Relationship Between Vitamin D Status and Brain Perfusion in Neuropsychiatric Lupus.

Authors:  Nasreen Sultana; Azmal Kabir Sarkar; Hiroshi Matsuda; Md Amimul Ihsan; Syed Atiqul Haq; Md Saidul Arefin; Sheikh Nazrul Islam
Journal:  Nucl Med Mol Imaging       Date:  2022-03-08

8.  Neuropsychiatric systemic lupus erythematosus.

Authors:  Alexandra Popescu; Amy H Kao
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

9.  Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.

Authors:  Fabrizio Conti; Cristiano Alessandri; Carlo Perricone; Rossana Scrivo; Soheila Rezai; Fulvia Ceccarelli; Francesca Romana Spinelli; Elena Ortona; Massimo Marianetti; Concetta Mina; Guido Valesini
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

10.  Abnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus.

Authors:  Jingming Hou; Yun Lin; Wei Zhang; Lingheng Song; Wenjing Wu; Jian Wang; Daiquan Zhou; Qinghua Zou; Yongfei Fang; Mei He; Haitao Li
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.